The Transformative Role of Biosimilars and Cost Reduction
The proliferation of Biosimilars—the generic equivalents of complex biologic drugs—is fundamentally reshaping the Biopharmaceutical Market, acting as a crucial mechanism for enhancing cost-effectiveness, improving patient access, and intensifying market competition. As patents for major blockbuster biologics expire, the entry of biosimilars is creating a "patent cliff" that is...
0 Comentários 0 Compartilhamentos 791 Visualizações 0 Anterior